glp 1 drugs and breast cancer GLP-1 Receptor Agonists Show a Striking Signal in Outcomes, but Big Questions Remain can you take glp 1

The effect of dipeptidyl peptidase-4 inhibitors on macrovascular and microvascular complications of diabetes mellitus: A systematic review

Referral to endocrinology, cardiology, or lipid specialists may be warranted for complex cases involving multiple cardiovascular risk factors, familial hypercholesterolemia, severe hypertriglyceridemia (500 mg/dL), or inadequate response to initial therapy

Until TAME and similar RCTs read out: prescribe it for diabetes, respect the kidney, stay skeptical of the off-label hype

States may offer broader coverage but cannot make coverage criteria more restrictive, and the Medicaid key terms must apply equally in both fee-for-service and Medicaid managed care

Each has different ingredient profiles and varying levels of evidence

[DOI] [PMC free article] [PubMed] [Google Scholar] 57.Exenatide treatment reduces thyroid gland volume, but has no effect on the size of the thyroid nodules